[HTML][HTML] Laboratory findings and biomarkers in long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and …

D Tsilingiris, NG Vallianou, I Karampela… - International Journal of …, 2023 - mdpi.com
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

[HTML][HTML] Cellular and molecular biomarkers of long COVID: a scoping review

E Espín, C Yang, CP Shannon, S Assadian, D He… - …, 2023 - thelancet.com
Summary Background Long-COVID (LC) encompasses diverse symptoms lasting months
after the initial SARS-CoV-2 infection. Symptoms can be debilitating and affect the quality of …

Identification and diagnosis of long COVID-19: a scoping review

S Srikanth, JR Boulos, T Dover, L Boccuto… - Progress in Biophysics …, 2023 - Elsevier
Abstract Long COVID-19 (LC-19) is a condition that has affected a high percentage of the
population that recovered from the initial disease caused by severe acute respiratory …

[HTML][HTML] Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets

G Kenny, L Townsend, S Savinelli… - Frontiers in Molecular …, 2023 - frontiersin.org
The emergence of persistent ill-health in the aftermath of SARS-CoV-2 infection has
presented significant challenges to patients, healthcare workers and researchers. Termed …

[HTML][HTML] The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID

J Li, Y Zhou, J Ma, Q Zhang, J Shao, S Liang… - … and Targeted Therapy, 2023 - nature.com
There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …

Sequelae of long COVID, known and unknown: A review of updated information

T Asakawa, Q Cai, J Shen, Y Zhang, Y Li, P Chen… - Bioscience …, 2023 - jstage.jst.go.jp
Over three years have passed since the COVID-19 pandemic started. The dangerousness
and impact of COVID-19 should definitely not be ignored or underestimated. Other than the …

Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments

SJ Yong - Infectious diseases, 2021 - Taylor & Francis
Long COVID or post-COVID-19 syndrome first gained widespread recognition among social
support groups and later in scientific and medical communities. This illness is poorly …

[HTML][HTML] Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: Opportunities and challenges

R Mittal, N Chourasia, VK Bharti, S Singh… - Journal of Family …, 2022 - journals.lww.com
The reasons for high morbidity and mortality with Corona virus disease (COVID-19) disease
remain unanswered with extremes of manifestation and uncertainty of modes of …

[HTML][HTML] Biomarkers in long COVID-19: A systematic review

YJ Lai, SH Liu, S Manachevakul, TA Lee… - Frontiers in …, 2023 - frontiersin.org
Purpose Long COVID, also known as post-acute sequelae of COVID-19, refers to the
constellation of long-term symptoms experienced by people suffering persistent symptoms …

[HTML][HTML] Long COVID: An inevitable sequela of SARS-CoV-2 infection

CC Lai, CK Hsu, MY Yen, PI Lee, WC Ko… - Journal of Microbiology …, 2023 - Elsevier
At present, there are more than 560 million confirmed cases of the coronavirus disease 2019
(COVID-19) worldwide. Although more than 98% of patients with severe acute respiratory …